You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VX-984

Showing 1 - 25 of 140
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in United States (VX-984 120 mg + PLD 40 mg/m^2, VX-984 240 mg + PLD 40 mg/m^2, VX-984 480 mg + PLD

Completed
Has Results
  • Advanced Solid Tumor
  • VX-984 120 mg + PLD 40 mg/m^2
  • +3 more
  • Scottsdale, Arizona
  • +4 more
Jul 29, 2019

Pain Trial (VX-548, Moxifloxacin, Moxifloxacin Placebo)

Not yet recruiting
  • Pain
  • (no location specified)
Apr 5, 2023

Cystic Fibrosis Trial (VX-121/TEZ/D-IVA)

Recruiting
  • Cystic Fibrosis
  • Aurora, Colorado
  • +16 more
Jan 19, 2023

Cystic Fibrosis Trial (VX-828, Placebo, Itraconazole)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
Nov 23, 2023

Cystic Fibrosis Trial (VX-121/TEZ/D-IVA)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
Sep 7, 2022

Pain Trial (VX-548)

Not yet recruiting
  • Pain
  • (no location specified)
Apr 28, 2023

Pain Trial in Harrow (VX-973, Placebo, Midazolam)

Recruiting
  • Pain
  • Harrow, United Kingdom
    PAREXEL International
May 17, 2023

Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

Active, not recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +169 more
Dec 22, 2022

Type 1 Diabetes Trial (VX-264)

Not yet recruiting
  • Type 1 Diabetes
  • (no location specified)
Mar 16, 2023

Cystic Fibrosis Trial in Miami, San Antonio (VX-121/TEZ/D-IVA)

Recruiting
  • Cystic Fibrosis
  • Miami, Florida
  • +1 more
Aug 4, 2022

Pain Trial in United States (VX-548)

Recruiting
  • Pain
  • Tucson, Arizona
  • +5 more
Feb 2, 2023

Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

Recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +128 more
Aug 24, 2022

Alpha-1 Antitrypsin Deficiency Trial (VX-668, Placebo)

Not yet recruiting
  • Alpha-1 Antitrypsin Deficiency
  • (no location specified)
Feb 3, 2023

Focal Segmental Glomerulosclerosis (FSGS) Trial (VX-147)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • (no location specified)
Jul 13, 2023

Diabetic Peripheral Neuropathy Trial in United States (VX-548, Pregabalin, Placebo (matched to VX-548))

Recruiting
  • Diabetic Peripheral Neuropathy
  • Banning, California
  • +10 more
Jan 30, 2023

Acute Pain Trial (VX-548, HB/APAP, Placebo (matched to VX-548))

Recruiting
  • Acute Pain
  • Sheffield, Alabama
  • +16 more
Jan 4, 2023

Acute Pain Trial in United States (VX-548, HB/APAP, Placebo (matched to VX-548))

Recruiting
  • Acute Pain
  • Sheffield, Alabama
  • +10 more
Jan 4, 2023

Cystic Fibrosis Trial in United States (VX-121/TEZ/D-IVA)

Recruiting
  • Cystic Fibrosis
  • Aurora, Colorado
  • +6 more
Jul 26, 2022

Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

Completed
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +96 more
Jan 12, 2023

Pain Trial in Manchester (VX-993, Placebo)

Recruiting
  • Pain
  • Manchester, United Kingdom
    MAC Clinical Research
Jan 6, 2023

Alpha 1-Antitrypsin Deficiency Trial in Tempe (VX-634, Placebo)

Recruiting
  • Alpha 1-Antitrypsin Deficiency
  • Tempe, Arizona
    Celerion - Tempe
Nov 9, 2022

Alpha-1 Antitrypsin Deficiency Trial in Hannibal, Houston (VX-864)

Recruiting
  • Alpha-1 Antitrypsin Deficiency
  • Hannibal, Missouri
  • +1 more
Dec 22, 2022

Pain Trial (VX-548)

Not yet recruiting
  • Pain
  • (no location specified)
Jan 19, 2023

Influenza Trial in Toronto, Mirabel, Pointe-Claire (H1 influenza antigen)

Completed
  • Influenza
  • H1 influenza antigen
  • Toronto, Ontario, Canada
  • +2 more
Nov 3, 2023

APOL1-mediated Kidney Disease Trial in Lenexa (VX-840, Placebo)

Completed
  • APOL1-mediated Kidney Disease
  • Lenexa, Kansas
    ICON Lenexa
Dec 6, 2022